{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T06:30:11Z","timestamp":1726468211787},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001214","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG4070B7\/2"],"award-info":[{"award-number":["RG4070B7\/2"]}],"id":[{"id":"10.13039\/100001214","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","award":["AI097375"],"award-info":[{"award-number":["AI097375"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.clim.2015.03.018","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T21:06:56Z","timestamp":1428268016000},"page":"103-113","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720"],"prefix":"10.1016","volume":"158","author":[{"given":"Mai","family":"Fujiwara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily J.","family":"Anstadt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal M.","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2015.03.018_bb0005","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa073493","article-title":"Risk alleles for multiple sclerosis identified by a genomewide study","volume":"357","author":"International Multiple Sclerosis Genetics, C.","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2015.03.018_bb0010","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"International Multiple Sclerosis Genetics, C.","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.clim.2015.03.018_bb0015","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng.584","article-title":"Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis","volume":"42","author":"Sanna","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2015.03.018_bb0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/35003228","article-title":"Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b","volume":"403","author":"Bachmaier","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.clim.2015.03.018_bb0025","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/35003235","article-title":"Cbl-b regulates the CD28 dependence of T-cell activation","volume":"403","author":"Chiang","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.clim.2015.03.018_bb0030","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.4049\/jimmunol.1003390","article-title":"Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions","volume":"186","author":"Paolino","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.03.018_bb0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.celrep.2014.01.012","article-title":"E3 ubiquitin ligase Cbl-b suppresses proallergic T cell development and allergic airway inflammation","volume":"6","author":"Qiao","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2015.03.018_bb0040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jmcb\/mjt017","article-title":"Cbl-b mediates TGFbeta sensitivity by downregulating inhibitory SMAD7 in primary T cells","volume":"5","author":"Gruber","year":"2013","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.clim.2015.03.018_bb0045","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.1001171","article-title":"Cbl-b(\u2212\/\u2212) T cells demonstrate in vivo resistance to regulatory T cells but a context-dependent resistance to TGF-beta","volume":"185","author":"Adams","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.03.018_bb0050","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.4049\/jimmunol.173.2.1059","article-title":"Resistance to CD4+CD25+ regulatory T cells and TGF-beta in Cbl-b\u2212\/\u2212 mice","volume":"173","author":"Wohlfert","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.03.018_bb0055","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1172\/JCI72973","article-title":"Decreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cells","volume":"124","author":"Kofler","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.clim.2015.03.018_bb0060","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1172\/JCI1528","article-title":"Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated\/memory T cells","volume":"101","author":"Lovett-Racke","year":"1998","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.clim.2015.03.018_bb0065","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1172\/JCI200112516","article-title":"CD4+CD28\u2212 costimulation-independent T cells in multiple sclerosis","volume":"108","author":"Markovic-Plese","year":"2001","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.clim.2015.03.018_bb0070","doi-asserted-by":"crossref","first-page":"170ra115","DOI":"10.1126\/scitranslmed.3004970","article-title":"In active relapsing\u2013remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling","volume":"5","author":"Schneider","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2015.03.018_bb0075","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.4049\/jimmunol.160.3.1532","article-title":"Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation","volume":"160","author":"Scholz","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.03.018_bb0080","doi-asserted-by":"crossref","first-page":"ra30","DOI":"10.1126\/scisignal.2000046","article-title":"PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation","volume":"2","author":"Gruber","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.clim.2015.03.018_bb0085","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.4049\/jimmunol.1303077","article-title":"A multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN function","volume":"193","author":"Sturner","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.03.018_bb0090","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.clim.2015.03.018_bb0095","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1074\/jbc.M610318200","article-title":"Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor","volume":"282","author":"Oo","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2015.03.018_bb0100","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.22426","article-title":"Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis","volume":"69","author":"Cohen","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2015.03.018_bb0105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2015.03.018_bb0110","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.intimp.2010.10.005","article-title":"Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-beta in mouse experimental autoimmune encephalomyelitis","volume":"11","author":"Chiba","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.clim.2015.03.018_bb0115","first-page":"439","article-title":"FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration","volume":"2","author":"Kataoka","year":"2005","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.clim.2015.03.018_bb0120","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.chembiol.2012.07.016","article-title":"A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis","volume":"19","author":"Quancard","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.clim.2015.03.018_bb0125","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1476-5381.2011.01579.x","article-title":"Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis","volume":"165","author":"Rossi","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.clim.2015.03.018_bb0130","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.clim.2015.03.018_bb0135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature02284","article-title":"Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1","volume":"427","author":"Matloubian","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.clim.2015.03.018_bb0140","doi-asserted-by":"crossref","first-page":"22328","DOI":"10.1074\/jbc.M110.123299","article-title":"CD69 suppresses sphingosine 1-phosphate receptor-1 (S1P1) function through interaction with membrane helix 4","volume":"285","author":"Bankovich","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2015.03.018_bb0145","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature04606","article-title":"CD69 acts downstream of interferon-alpha\/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs","volume":"440","author":"Shiow","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.clim.2015.03.018_bb0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.immuni.2007.11.017","article-title":"S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress","volume":"28","author":"Pham","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2015.03.018_bb0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1084\/jem.191.1.61","article-title":"The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules","volume":"191","author":"Stein","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2015.03.018_bb0160","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1126\/science.1113640","article-title":"Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients","volume":"309","author":"Schwab","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.clim.2015.03.018_bb0165","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1074\/jbc.M311743200","article-title":"Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate","volume":"279","author":"Sanna","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2015.03.018_bb0170","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/nbm.3012","article-title":"Diffusion tensor imaging detects treatment effects of FTY720 in experimental autoimmune encephalomyelitis mice","volume":"26","author":"Wang","year":"2013","journal-title":"NMR Biomed."},{"key":"10.1016\/j.clim.2015.03.018_bb0175","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S1474-4422(08)70241-2","article-title":"Genome-wide association studies in neurological disorders","volume":"7","author":"Simon-Sanchez","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2015.03.018_bb0180","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.neulet.2008.05.089","article-title":"Study of Cbl-b dynamics in peripheral blood lymphocytes isolated from patients with multiple sclerosis","volume":"440","author":"Zhou","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.clim.2015.03.018_bb0185","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.4049\/jimmunol.176.3.1316","article-title":"Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo","volume":"176","author":"Wohlfert","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.03.018_bb0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.immuni.2004.07.013","article-title":"Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction","volume":"21","author":"Jeon","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2015.03.018_bb0195","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ni0901-870","article-title":"Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells","volume":"2","author":"Fang","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2015.03.018_bb0200","doi-asserted-by":"crossref","first-page":"7632","DOI":"10.4049\/jimmunol.178.12.7632","article-title":"Kruppel-like factor 2 controls T cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription","volume":"178","author":"Bai","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.03.018_bb0205","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nature04882","article-title":"Kruppel-like factor 2 regulates thymocyte and T-cell migration","volume":"442","author":"Carlson","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.clim.2015.03.018_bb0210","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.4049\/jimmunol.181.5.2980","article-title":"FOXO1 regulates L-selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase","volume":"181","author":"Fabre","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.03.018_bb0215","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1749-6632.2009.05134.x","article-title":"Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration","volume":"1183","author":"Finlay","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.clim.2015.03.018_bb0220","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1084\/jem.20100004","article-title":"Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells","volume":"207","author":"Harada","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2015.03.018_bb0225","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4049\/jimmunol.1202068","article-title":"T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells","volume":"191","author":"Qiao","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.03.018_bb0230","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1084\/jem.20091343","article-title":"Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics","volume":"207","author":"Thangada","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2015.03.018_bb0235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2013.02.011","article-title":"Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy","volume":"328","author":"Groves","year":"2013","journal-title":"J. Neurol. Sci."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661615001217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661615001217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T06:34:31Z","timestamp":1691562871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661615001217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1521661615001217"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2015.03.018","relation":{},"ISSN":["1521-6616"],"issn-type":[{"type":"print","value":"1521-6616"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2015.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}